CY1115490T1 - Στερεο παρασκευασμα που περιεχει μια μονη κρυσταλλικη μορφη - Google Patents

Στερεο παρασκευασμα που περιεχει μια μονη κρυσταλλικη μορφη

Info

Publication number
CY1115490T1
CY1115490T1 CY20141100662T CY141100662T CY1115490T1 CY 1115490 T1 CY1115490 T1 CY 1115490T1 CY 20141100662 T CY20141100662 T CY 20141100662T CY 141100662 T CY141100662 T CY 141100662T CY 1115490 T1 CY1115490 T1 CY 1115490T1
Authority
CY
Cyprus
Prior art keywords
single crystal
crystal form
container containing
strong container
strong
Prior art date
Application number
CY20141100662T
Other languages
English (en)
Inventor
Michio Iwai
Kazuhiro Nakamura
Masahiko Dohi
Hiroko Mochizuki
Seiji Mochizuki
Original Assignee
Teijin Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28671666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1115490(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Pharma Limited filed Critical Teijin Pharma Limited
Publication of CY1115490T1 publication Critical patent/CY1115490T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Abstract

Ένα στερεό παρασκεύασμα που περιέχει 2-(3-κυανο-4-ισοβουτυλοξυφαινυλ)-4-μεθυλ-5-θειαζολοκαρβοξυλικό οξύ σε μία μόνη κρυσταλλική μορφή, ένα έκδοχο και έναν παράγοντα αποσύνθεσης, και μία μέθοδος για παραγωγή του στερεού παρασκευάσματος.
CY20141100662T 2002-03-28 2014-08-20 Στερεο παρασκευασμα που περιεχει μια μονη κρυσταλλικη μορφη CY1115490T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002090889 2002-03-28
EP03715586.8A EP1488790B1 (en) 2002-03-28 2003-03-28 Solid preparation containing a single crystal a form of a thiazolecarboxylic acid derivative

Publications (1)

Publication Number Publication Date
CY1115490T1 true CY1115490T1 (el) 2017-01-04

Family

ID=28671666

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100662T CY1115490T1 (el) 2002-03-28 2014-08-20 Στερεο παρασκευασμα που περιεχει μια μονη κρυσταλλικη μορφη

Country Status (13)

Country Link
US (1) US7361676B2 (el)
EP (1) EP1488790B1 (el)
JP (1) JP4084309B2 (el)
KR (1) KR100981905B1 (el)
CN (2) CN1642546A (el)
AU (1) AU2003220909B2 (el)
CA (1) CA2474674C (el)
CY (1) CY1115490T1 (el)
DK (1) DK1488790T3 (el)
ES (1) ES2505690T3 (el)
PT (1) PT1488790E (el)
SI (1) SI1488790T1 (el)
WO (1) WO2003082279A1 (el)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065885A1 (en) 1998-06-19 1999-12-23 Teijin Limited Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
CN100430055C (zh) * 2005-11-11 2008-11-05 天津泰普药品科技发展有限公司 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸和聚乙烯吡咯烷酮玻璃态固溶体及其制备方法
CN101139325B (zh) * 2006-09-07 2010-05-12 上海医药工业研究院 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
CN101812035B (zh) * 2006-09-07 2012-03-21 上海医药工业研究院 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
JP2010509372A (ja) * 2006-11-13 2010-03-25 タケダ・フアーマシユーテイカルズ・ノース・アメリカ・インコーポレイテツド キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法
CN102093308B (zh) * 2006-12-07 2012-08-29 重庆医药工业研究院有限责任公司 非布司他的晶型及其制备方法
CN1970547B (zh) * 2006-12-07 2011-04-06 重庆医药工业研究院有限责任公司 非布司他的晶型及其制备方法
CN101412700B (zh) * 2007-10-19 2011-06-08 上海医药工业研究院 非布司他的晶型及其制备方法
CN101386605B (zh) * 2008-10-23 2010-09-08 中国科学院上海药物研究所 非布司他新型晶体及其制备方法
CN101474175B (zh) * 2009-01-20 2014-07-02 重庆医药工业研究院有限责任公司 一种高生物利用度非布司他口服固体制剂及其制备方法
CN101780073B (zh) * 2009-01-21 2013-07-03 重庆圣华曦药业股份有限公司 非布司他分散片药物及其制备方法
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
EP2532654A1 (en) 2009-06-10 2012-12-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of febuxostat
CN102070558B (zh) * 2009-11-23 2012-08-22 欣凯医药化工中间体（上海）有限公司 非布索坦的新晶型及其制备方法
CN101824005B (zh) * 2010-04-27 2012-06-27 上海凯米侬医药科技有限公司 一种非布索坦的晶型q及其制备方法
WO2011158870A1 (ja) * 2010-06-16 2011-12-22 帝人ファーマ株式会社 放出制御型の有核錠剤
ES2553584T3 (es) 2010-06-25 2015-12-10 Sandoz Ag Polimorfos de Febuxostat
EP2591774B1 (en) * 2010-07-09 2020-05-27 Teijin Pharma Limited Orally disintegrating tablet
RU2013109380A (ru) 2010-09-10 2014-10-20 Такеда Фармасьютикалс Ю.С.А.,Инк. Способ сопутствующей терапии с применением теофиллина и фебуксостата
EP2502920A1 (en) 2011-03-25 2012-09-26 Sandoz Ag Crystallization process of Febuxostat from A
WO2012153313A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Pharmaceutical composition of febuxostat
US20140112992A1 (en) * 2011-06-06 2014-04-24 Hetero Research Foundation Process for febuxostat
WO2013001441A1 (en) * 2011-06-29 2013-01-03 Ranbaxy Laboratories Limited Dry formulations of febuxostat
WO2013088449A1 (en) 2011-12-16 2013-06-20 Natco Pharma Limited Stable crystal form of febuxostat and process for the preparation thereof
EP2925306A1 (en) 2012-07-12 2015-10-07 Alembic Pharmaceuticals Limited Pharmaceutical composition of febuxostat
EP2692342A1 (en) * 2012-07-30 2014-02-05 Interquim, S.A. Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets
US20140051733A1 (en) * 2012-08-14 2014-02-20 Dr. Reddy's Laboratories Ltd. Febuxostat pharmaceutical compositions
WO2014057461A1 (en) 2012-10-11 2014-04-17 Ranbaxy Laboratories Limited Process for the preparation of crystalline form g of febuxostat
WO2014125504A2 (en) * 2013-02-18 2014-08-21 Hetero Research Foundation Pharmaceutical compositions of febuxostat
US20140357683A1 (en) 2013-05-31 2014-12-04 Takeda Pharmaceuticals U.S.A., Inc. Methods of treatment and compositions with xanthine oxidase inhibitors
CN103588724B (zh) * 2013-09-10 2015-05-20 杭州华东医药集团新药研究院有限公司 一种非布司他晶型a及其制备方法
CN103588723B (zh) * 2013-09-10 2015-05-20 杭州华东医药集团新药研究院有限公司 一种非布司他晶型a的制备方法
WO2015063561A1 (ja) * 2013-10-22 2015-05-07 日本ケミファ株式会社 2—[3—シアノ—4—（2—メチルプロポキシ）フェニル]—4—メチルチアゾ一ル—5—力ルボン酸の小型化結晶、その微粉化物及びこれらを含有する固形製剤
EP2881116A1 (en) 2013-12-05 2015-06-10 Ranbaxy Laboratories Limited Febuxostat composition
EP2902016A1 (en) 2014-01-30 2015-08-05 Alfred E. Tiefenbacher (GmbH & Co. KG) Febuxostat tablet
CZ27857U1 (cs) 2014-12-12 2015-02-23 Zentiva, K.S. Formulace obsahující tuhý roztok febuxostatu
WO2016171254A1 (ja) * 2015-04-22 2016-10-27 日本ケミファ株式会社 ２－［３－シアノ－４－（２－メチルプロポキシ）フェニル］－４－メチルチアゾール－５－カルボン酸の結晶、その製造方法、及びそれらの利用
GR1009119B (el) * 2016-06-30 2017-09-18 "Φαρματεν Α.Β.Ε.Ε." Φαρμακευτικο σκευασμα περιεχον ενα μη πουρινικο επιλεκτικο αναστολεα της οξειδασης της ξανθινης και μεθοδος παρασκευης αυτου
CN106511288A (zh) * 2016-12-20 2017-03-22 天津泰普制药有限公司 一种非布司他片剂的制备方法
CN110199236A (zh) 2017-04-25 2019-09-03 惠普发展公司，有限责任合伙企业 流体叶轮控制器
JP2019142814A (ja) * 2018-02-21 2019-08-29 大原薬品工業株式会社 フェブキソスタット含有錠剤の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218942B (hu) 1990-11-30 2001-01-29 Teijin Ltd. 2-Fenil-tiazol-származékok, az ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására
ES2224160T3 (es) * 1995-04-07 2005-03-01 Teijin Limited Agente protector para organo o tejido.
WO1997028130A1 (fr) * 1996-02-02 1997-08-07 Nippon Shinyaku Co., Ltd. Derives de l'isoquinoline et medicaments associes
WO1999065885A1 (en) * 1998-06-19 1999-12-23 Teijin Limited Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet

Also Published As

Publication number Publication date
CN1642546A (zh) 2005-07-20
CN101836978B (zh) 2013-09-11
ES2505690T3 (es) 2014-10-10
DK1488790T3 (da) 2014-10-13
CA2474674A1 (en) 2003-10-09
JPWO2003082279A1 (ja) 2005-07-28
KR20040101284A (ko) 2004-12-02
CA2474674C (en) 2011-04-19
AU2003220909B2 (en) 2008-09-18
EP1488790A4 (en) 2007-06-20
US20050043375A1 (en) 2005-02-24
PT1488790E (pt) 2014-10-10
CN101836978A (zh) 2010-09-22
EP1488790A1 (en) 2004-12-22
US7361676B2 (en) 2008-04-22
AU2003220909A1 (en) 2003-10-13
KR100981905B1 (ko) 2010-09-13
SI1488790T1 (sl) 2014-09-30
WO2003082279A1 (fr) 2003-10-09
JP4084309B2 (ja) 2008-04-30
EP1488790B1 (en) 2014-07-16

Similar Documents

Publication Publication Date Title
CY1115490T1 (el) Στερεο παρασκευασμα που περιεχει μια μονη κρυσταλλικη μορφη
WO2003059563A3 (de) Femtosekunden-lasersystem zur präzisen bearbeitung von material und gewebe
AU2003304482A1 (en) Method and apparatus for single-photon source and quantum memory
NO20053586L (no) Platemateriale for et radiobolgeabsorberende legeme, og radiobolgeabsorberende legeme.
CY1124650T1 (el) Φαρμακευτικο παρασκευασμα που περιεχει ινσουλινη σε κρυσταλλικη μορφη καθως και σε διαλυτοποιημενη μορφη
HK1052450A1 (en) Bone plate for osteosynthesis.
BR0215924B1 (pt) dispositivo para osteossìntese.
TW200619847A (en) Photosensitive composition, compound for use in the photosensitive composition, and pattern-forming method using the photosensitive composition
NO20031273L (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
DE50311338D1 (de) Wirkstoffhaltige filmförmige zubereitungen mit verbesserter chemischer stabilität, und verfahren zu deren herstellung
AU2003282391A1 (en) Multiple-chamber medical container and method for producing the same
ITMI20031343A1 (it) Confezione plurima, e macchina e metodo per la sua fabbricazione.
ITMI20030776A1 (it) Dispositivo per pesare contenitori farmaceutici.
NO20014861D0 (no) Fremgangsmåte og anordning for pakking av engangsartikler samt artiklene som tilveiebringes
BR0314838A (pt) Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida
NO20031453L (no) Bronnsystem, enhetsmodul for bruk i bronnsystemet og fremgangsmate for dannelse av et bronnsystem
AU2002367863A1 (en) Methods for sterilizing biological materials
TW200510362A (en) Amorphous simvastatin calcium and methods for the preparation thereof
DE50302811D1 (de) Vorrichtung zum herstellen von zigaretten-packungen
ITRM20030471A0 (it) Dispositivo di taglio di contenitori sanitari, in particolare sacche,borse e/o presidi per stomie.
ITMI20030410A1 (it) Dispositivo di trasporto, particolarmente per contenitori farmaceutici.
BRPI0507153A (pt) composto, composição farmacêutica para uso oftálmico, e, processo para a preparação do sal de maleato de ibopamina
HK1152699A1 (en) Method for preparing trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2- trimethylpiperazine and the salts thereof and the intermediates used therein
AU2830401A (en) Amphiphilic polyamines, the use and method for synthesis thereof
EP1657245A4 (en) ORGANO-IRIDIUM COMPOUND, METHOD OF MANUFACTURING THE SAME, AND METHOD OF MANUFACTURING THE SAME